Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-12-08

Clinical Trial Update: Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing oral vancomycin followed by fecal microbiota transplantation versus tapering oral vancomycin was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)
  • oral vancomycin (vancomycin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Recurrent Clostridium Difficile Infection, Laboratory Confirmed Clostridium Difficile Infection | Phase 2, Phase 3 | Status: TERMINATED